Comparison of two different bone anchored hearing instruments: Baha-5 vs Ponto-plus

Küçük Resim Yok

Tarih

2019

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Taylor & Francis Online

Erişim Hakkı

info:eu-repo/semantics/openAccess

Araştırma projeleri

Organizasyon Birimleri

Dergi sayısı

Özet

Background: To our knowledge, there is no study comparing Ponto Plus® (Oticon Medical AB, Askim, Sweden) and Baha® 5 (Cochlear Bone Anchored Solutions AG, Mölnlycke, Sweden) available in the literature. Aims/objectives: The primary aim was to compare the performance of the Baha 5 with the Ponto Plus device in terms of speech understanding in quiet and in noise. In addition, to determine statistically whether or not the difference between the abutment systems created any variation in terms of skin reaction. Materials and methods: Twenty bone-anchored hearing instrument users, ten in each group, were evaluated for speech understanding in quiet and several signal-to-noise ratios using the Turkish Matrix Test in a two-speaker setup. The Holger classifications were also reviewed to determine adverse skin reactions. Results: It was revealed that the hearing results of both devices were similar and, when the skin reactions were compared, there was no statistically significant difference between the two-implant systems. Conclusions and significance: Because of the similar results of the groups, it can be interpreted as the key different device features such as the size, weight, colour alternatives, and the ease of use of the devices might be important in terms of device preference.

Açıklama

Anahtar Kelimeler

Hearing aid, noise, bone conduction hearing, speech intelligibility

Kaynak

Acta Oto-Laryngologica

WoS Q Değeri

Scopus Q Değeri

Q2

Cilt

139

Sayı

6

Künye

Kara, A., Güven, M., Yılmaz, M.S., Demir, D., Adigul, Ç., Durgut, M., Elden, H., Mutlu, F. ve İşeri, M. (2019). Comparison of two different bone anchored hearing instruments: Baha-5 vs Ponto-plus. Acta Oto-Laryngologica, Taylor & Francis Online. 139(6), s. 517-521.